HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.

AbstractOBJECTIVE:
To investigate the clinical features of COVID-19 cases in Suzhou China. Biomarkers were screened out of hematological parameters for risk stratification.
METHOD:
Confirmed COVID-19 adult patients in Suzhou were included. The patient data was collected, and the results of laboratory examinations were compared between the mild/moderate and severe COVID-19 groups. A ROC was calculated to compare the diagnostic performance of candidate indexes, and dynamic levels of hematological indexes were compared between the two groups.
RESULT:
75 patients were enrolled, with a mean age of 46.6 ± 14 years, and 45 patients were male. All patients were classified into two groups: the mild/moderate group and the severe group. WBC, neutrophil to lymphocyte ratio (NLR), D-dimer, and fibrinogen levels of the severe group were significantly higher (P < 0.05) than the mild/moderate, and the lymphocyte was lower. The ROC test showed that the hematological parameters had a larger AUC than that of inflammatory factors. There was a significant difference in lymphocyte and fibrinogen levels between the two groups on day 1 (P < 0.05). However, NLR of the severe group was higher than the mild/moderate on days 1, 4 and 14 (P < 0.01), and so was D-dimer on days 1, 7 and 14 (P < 0.05).
CONCLUSION:
The common COVID-19 abnormal hematological indexes on admission included hyperfibrinogenemia, lymphopenia, the elevation of D-dimer, and leukopenia, which were significantly different between the mild/moderate and severe COVID-19 groups. Furthermore, the dynamic change of NLR and D-dimer level can distinguish severe COVID-19 cases from the mild/moderate.
AuthorsJianhong Fu, Jindan Kong, Wei Wang, Meiying Wu, Lin Yao, Zhaoyue Wang, Jun Jin, Depei Wu, Xin Yu
JournalThrombosis research (Thromb Res) Vol. 192 Pg. 3-8 (08 2020) ISSN: 1879-2472 [Electronic] United States
PMID32407937 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2020 Elsevier Ltd. All rights reserved.
Chemical References
  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
Topics
  • Adult
  • Aged
  • Betacoronavirus (pathogenicity)
  • Biomarkers (blood)
  • COVID-19
  • COVID-19 Testing
  • China
  • Clinical Laboratory Techniques
  • Coronavirus Infections (blood, diagnosis, therapy, virology)
  • Female
  • Fibrin Fibrinogen Degradation Products (analysis)
  • Host-Pathogen Interactions
  • Humans
  • Lymphocyte Count
  • Lymphocytes
  • Male
  • Middle Aged
  • Neutrophils
  • Pandemics
  • Pneumonia, Viral (blood, diagnosis, therapy, virology)
  • Predictive Value of Tests
  • Prognosis
  • Reproducibility of Results
  • Retrospective Studies
  • SARS-CoV-2
  • Severity of Illness Index
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: